# FDA WARNING_LETTER - benjaminmcevoy.com - May 12, 2020

Source: https://www.keypedia.com/records/warning_letter/benjaminmcevoycom/f06a5845-5ab7-4b05-ade7-1c87a4bc9508

> FDA WARNING_LETTER for benjaminmcevoy.com on May 12, 2020. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: WARNING_LETTER
- Company Name: benjaminmcevoy.com
- Inspection Date: 2020-05-12
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research
- Summary: On May 14, 2020, the FDA and FTC issued a Warning Letter to Benjamin McEvoy regarding unapproved and misbranded products related to COVID-19. The agencies reviewed www.benjaminmcevoy.com on May 6 and May 12, 2020, observing that the website participates in the Amazon Associates program, promoting dietary supplements with claims implying they can mitigate, prevent, treat, diagnose, or cure COVID-19.

These claims cause the Amazon associate products to be unapproved new drugs under section 505(a) of the FD&C Act (21 U.S.C. § 355(a)) and misbranded drugs under section 502 (21 U.S.C. § 352). Introducing or delivering these products into interstate commerce is prohibited under sections 301(a) and (d) (21 U.S.C. § 331(a) and (d)), and misbranding after shipment in interstate commerce is prohibited under section 301(k) (21 U.S.C. § 331(k)).

The letter cites examples of claims from https://benjaminmcevoy.com/top-7-supplements-boosting-immune-system/ that establish intended use for COVID-19. The FDA requests immediate cessation of promoting and participating

## Related Officers

- [Director](https://www.keypedia.com/people/donald-d-ashley/060f0dda-e6e8-4f9c-97e7-f540d523d902)
- [Richard A. Quaresima](https://www.keypedia.com/people/richard-a-quaresima/d0be06fa-21e5-46d0-879d-95af9663066c)

Company: https://www.keypedia.com/companies/benjaminmcevoycom/d92b0318-873c-4680-8e03-43b349ce851c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c